NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination ...Middle East

RADNOR, Pa., Jan. 17, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx" or the "Company"), a clinical-stage biopharmaceutical company developing therapies for suicidal depression, chronic pain, and PTSD, today announced that on January 16, 2024, the Company was notified...

Hence then, the article about nrx pharmaceuticals inc nasdaq nrxp announces receipt of positive nasdaq listing determination was published today ( Wednesday 17/01/2024 - 02:53 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt of Positive Nasdaq Listing Determination )

Also on site :

• 1969 Summer Anthem, Named One of the Greatest Songs of All Time, Blew up After Woodstock
• Unwanted Vinyl? No Problem: Inside Warner Music Group’s Quest to Make Recycled Vinyl the Norm
• Walmart Has a 'Lightweight' 2-Piece Lounge Set That's 'Great for Summer' for Just $14